| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-catenin binding | 2.69e-06 | 120 | 37 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | BRE binding | 3.34e-06 | 2 | 37 | 2 | GO:0042835 | |
| GeneOntologyMolecularFunction | mediator complex binding | 2.00e-05 | 4 | 37 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | cadherin binding | 3.42e-05 | 339 | 37 | 6 | GO:0045296 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.93e-05 | 599 | 37 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.29e-04 | 53 | 37 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | large ribosomal subunit rRNA binding | 1.82e-04 | 11 | 37 | 2 | GO:0070180 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 3.75e-04 | 76 | 37 | 3 | GO:0098631 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 4.46e-04 | 17 | 37 | 2 | GO:0000900 | |
| GeneOntologyMolecularFunction | cadherin binding involved in cell-cell adhesion | 5.60e-04 | 19 | 37 | 2 | GO:0098641 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 6.86e-04 | 21 | 37 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.81e-03 | 34 | 37 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.20e-03 | 739 | 37 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.31e-03 | 303 | 37 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.59e-03 | 562 | 37 | 5 | GO:0003712 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 5.41e-05 | 237 | 36 | 5 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 5.98e-05 | 242 | 36 | 5 | GO:0098727 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 6.21e-05 | 244 | 36 | 5 | GO:0022618 | |
| GeneOntologyBiologicalProcess | translation | 7.01e-05 | 824 | 36 | 8 | GO:0006412 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 7.51e-05 | 254 | 36 | 5 | GO:0071826 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 1.02e-04 | 52 | 36 | 3 | GO:0006376 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.48e-04 | 59 | 36 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.66e-04 | 14 | 36 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.50e-04 | 16 | 36 | 2 | GO:0060211 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 3.52e-04 | 79 | 36 | 3 | GO:0000380 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 2.35e-04 | 13 | 37 | 2 | GO:1990907 | |
| Domain | BCL9_beta-catenin-bd_dom | 3.61e-06 | 2 | 36 | 2 | IPR024670 | |
| Domain | BCL9 | 3.61e-06 | 2 | 36 | 2 | PF11502 | |
| Domain | Bcl-9 | 3.61e-06 | 2 | 36 | 2 | IPR015668 | |
| Domain | RRM | 7.80e-04 | 217 | 36 | 4 | SM00360 | |
| Domain | RRM_dom | 9.23e-04 | 227 | 36 | 4 | IPR000504 | |
| Domain | RRM | 9.69e-04 | 230 | 36 | 4 | PS50102 | |
| Domain | Cadherin_C | 1.05e-03 | 25 | 36 | 2 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.05e-03 | 25 | 36 | 2 | IPR000233 | |
| Domain | - | 1.21e-03 | 244 | 36 | 4 | 3.30.70.330 | |
| Domain | Catenin_binding_dom | 1.42e-03 | 29 | 36 | 2 | IPR027397 | |
| Domain | - | 1.42e-03 | 29 | 36 | 2 | 4.10.900.10 | |
| Domain | Nucleotide-bd_a/b_plait | 1.48e-03 | 258 | 36 | 4 | IPR012677 | |
| Domain | UBA-like | 6.76e-03 | 64 | 36 | 2 | IPR009060 | |
| Domain | RRM_1 | 7.42e-03 | 208 | 36 | 3 | PF00076 | |
| Domain | SAM_1 | 7.60e-03 | 68 | 36 | 2 | PF00536 | |
| Pubmed | A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. | 2.40e-08 | 6 | 38 | 3 | 10893231 | |
| Pubmed | 4.20e-08 | 7 | 38 | 3 | 27512039 | ||
| Pubmed | BCL9L NCOA3 NCOA6 ZNF143 BCL9 SMC3 SMAP2 ATAD5 CNOT1 GLI3 TNRC6A | 2.34e-07 | 1429 | 38 | 11 | 35140242 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 9.56e-07 | 724 | 38 | 8 | 36232890 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22049795 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 20682801 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 8758910 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 38811552 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 33767438 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 30771902 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15371335 | ||
| Pubmed | 2.09e-06 | 83 | 38 | 4 | 28794006 | ||
| Pubmed | Cadherins Interact With Synaptic Organizers to Promote Synaptic Differentiation. | 3.48e-06 | 3 | 38 | 2 | 29760652 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 34545187 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 33649334 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 20637214 | ||
| Pubmed | miRISC and the CCR4-NOT complex silence mRNA targets independently of 43S ribosomal scanning. | 3.48e-06 | 3 | 38 | 2 | 27009120 | |
| Pubmed | 5.21e-06 | 638 | 38 | 7 | 31182584 | ||
| Pubmed | 6.37e-06 | 425 | 38 | 6 | 24999758 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 28957665 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 19699733 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 23172285 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 30197236 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 9.63e-06 | 457 | 38 | 6 | 32344865 | |
| Pubmed | Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. | 1.16e-05 | 5 | 38 | 2 | 30760710 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 17052462 | ||
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 1.16e-05 | 5 | 38 | 2 | 24360964 | |
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 1.16e-05 | 5 | 38 | 2 | 32808927 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 19328798 | ||
| Pubmed | 1.36e-05 | 486 | 38 | 6 | 20936779 | ||
| Pubmed | Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer. | 1.74e-05 | 6 | 38 | 2 | 30760720 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 17113272 | ||
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 15574752 | ||
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 11158314 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 1.74e-05 | 6 | 38 | 2 | 25184676 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 19228979 | ||
| Pubmed | MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. | 1.74e-05 | 6 | 38 | 2 | 19720736 | |
| Pubmed | 2.09e-05 | 1103 | 38 | 8 | 34189442 | ||
| Pubmed | Characterization of cadherins expressed by murine thymocytes. | 2.43e-05 | 7 | 38 | 2 | 8620560 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 8879495 | ||
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 30366904 | ||
| Pubmed | Gli3-mediated repression of Hedgehog targets is required for normal mammary development. | 2.43e-05 | 7 | 38 | 2 | 16914490 | |
| Pubmed | 2.96e-05 | 162 | 38 | 4 | 15174051 | ||
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 24768540 | ||
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 3.24e-05 | 8 | 38 | 2 | 28296634 | |
| Pubmed | 3.68e-05 | 347 | 38 | 5 | 16033648 | ||
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 3.75e-05 | 59 | 38 | 3 | 28813667 | |
| Pubmed | Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression. | 3.91e-05 | 174 | 38 | 4 | 29669786 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 4.46e-05 | 180 | 38 | 4 | 35198878 | |
| Pubmed | Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. | 5.20e-05 | 10 | 38 | 2 | 2059658 | |
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 10861224 | ||
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 21984185 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 36613751 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 21984184 | ||
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 22102170 | ||
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 20871603 | ||
| Pubmed | 9.33e-05 | 80 | 38 | 3 | 35803934 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 28174279 | ||
| Pubmed | 1.21e-04 | 15 | 38 | 2 | 33833667 | ||
| Pubmed | 1.21e-04 | 15 | 38 | 2 | 17925232 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 1.21e-04 | 15 | 38 | 2 | 21981923 | |
| Pubmed | Mouse thalamic differentiation: gli-dependent pattern and gli-independent prepattern. | 1.38e-04 | 16 | 38 | 2 | 22371696 | |
| Pubmed | 1.52e-04 | 469 | 38 | 5 | 27634302 | ||
| Pubmed | Lis1-Nde1-dependent neuronal fate control determines cerebral cortical size and lamination. | 1.76e-04 | 18 | 38 | 2 | 18469343 | |
| Pubmed | SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression. | 1.76e-04 | 18 | 38 | 2 | 29996942 | |
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 24066094 | ||
| Pubmed | 1.82e-04 | 1116 | 38 | 7 | 31753913 | ||
| Pubmed | 1.93e-04 | 263 | 38 | 4 | 34702444 | ||
| Pubmed | 1.96e-04 | 19 | 38 | 2 | 19666823 | ||
| Pubmed | 2.07e-04 | 268 | 38 | 4 | 33640491 | ||
| Pubmed | 2.18e-04 | 20 | 38 | 2 | 11877444 | ||
| Pubmed | E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. | 2.18e-04 | 20 | 38 | 2 | 7806582 | |
| Pubmed | 2.18e-04 | 20 | 38 | 2 | 14611647 | ||
| Pubmed | 2.41e-04 | 21 | 38 | 2 | 19596656 | ||
| Pubmed | 2.51e-04 | 282 | 38 | 4 | 23667531 | ||
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 19737349 | ||
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 9225980 | ||
| Pubmed | Dual mechanism underlying failure of neural tube closure in the Zic2 mutant mouse. | 3.16e-04 | 24 | 38 | 2 | 36916392 | |
| Pubmed | Type II cadherins guide assembly of a direction-selective retinal circuit. | 3.16e-04 | 24 | 38 | 2 | 25126785 | |
| Pubmed | 3.43e-04 | 25 | 38 | 2 | 20301702 | ||
| Pubmed | 3.43e-04 | 25 | 38 | 2 | 22479201 | ||
| Pubmed | 3.43e-04 | 25 | 38 | 2 | 21182203 | ||
| Pubmed | Phrenic-specific transcriptional programs shape respiratory motor output. | 4.01e-04 | 27 | 38 | 2 | 31944180 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.10e-04 | 582 | 38 | 5 | 20467437 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 4.15e-04 | 322 | 38 | 4 | 39098523 | |
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 4.18e-04 | 133 | 38 | 3 | 15604093 | |
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 4.63e-04 | 29 | 38 | 2 | 22036570 | |
| Pubmed | 4.63e-04 | 29 | 38 | 2 | 18239623 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 4.89e-04 | 934 | 38 | 6 | 33916271 | |
| Pubmed | 4.96e-04 | 30 | 38 | 2 | 23042737 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 5.47e-04 | 954 | 38 | 6 | 36373674 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.74e-04 | 351 | 38 | 4 | 38297188 | |
| Pubmed | 5.74e-04 | 963 | 38 | 6 | 28671696 | ||
| Pubmed | 6.01e-04 | 33 | 38 | 2 | 27414999 | ||
| Pubmed | The transcription factor Otx2 regulates choroid plexus development and function. | 6.01e-04 | 33 | 38 | 2 | 23364326 | |
| Pubmed | 6.17e-04 | 152 | 38 | 3 | 38360978 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 6.18e-04 | 358 | 38 | 4 | 32460013 | |
| Pubmed | 6.76e-04 | 35 | 38 | 2 | 20943929 | ||
| Pubmed | 7.26e-04 | 1007 | 38 | 6 | 34597346 | ||
| Pubmed | Chromatin Remodeling BAF155 Subunit Regulates the Genesis of Basal Progenitors in Developing Cortex. | 7.97e-04 | 38 | 38 | 2 | 30240734 | |
| Interaction | SMG7 interactions | 1.93e-06 | 319 | 38 | 7 | int:SMG7 | |
| Interaction | SOX2 interactions | SRP54 BCL9L NCOA3 MACF1 NCOA6 RPLP0 BCL9 SMC3 ATAD5 CNOT1 GLI3 TNRC6A | 7.01e-06 | 1422 | 38 | 12 | int:SOX2 |
| Interaction | TNRC6A interactions | 1.30e-05 | 280 | 38 | 6 | int:TNRC6A | |
| Interaction | CEP85 interactions | 1.57e-05 | 169 | 38 | 5 | int:CEP85 | |
| Interaction | ALG13 interactions | 2.30e-05 | 183 | 38 | 5 | int:ALG13 | |
| Interaction | FEV interactions | 3.78e-05 | 203 | 38 | 5 | int:FEV | |
| Interaction | RBMS1 interactions | 4.15e-05 | 207 | 38 | 5 | int:RBMS1 | |
| Interaction | CDH18 interactions | 7.23e-05 | 7 | 38 | 2 | int:CDH18 | |
| Interaction | SAMD13 interactions | 7.23e-05 | 7 | 38 | 2 | int:SAMD13 | |
| Interaction | CEBPA interactions | 7.51e-05 | 1245 | 38 | 10 | int:CEBPA | |
| Interaction | OTUD4 interactions | 7.73e-05 | 236 | 38 | 5 | int:OTUD4 | |
| Interaction | CDH7 interactions | 9.62e-05 | 8 | 38 | 2 | int:CDH7 | |
| Interaction | CDH6 interactions | 9.62e-05 | 8 | 38 | 2 | int:CDH6 | |
| Interaction | R3HDM2 interactions | 9.99e-05 | 129 | 38 | 4 | int:R3HDM2 | |
| Interaction | PAX9 interactions | 1.03e-04 | 130 | 38 | 4 | int:PAX9 | |
| Interaction | TNRC6C interactions | 1.30e-04 | 138 | 38 | 4 | int:TNRC6C | |
| Interaction | NUP35 interactions | 1.31e-04 | 424 | 38 | 6 | int:NUP35 | |
| Interaction | PRRC2B interactions | 1.33e-04 | 265 | 38 | 5 | int:PRRC2B | |
| Interaction | DAZL interactions | 1.57e-04 | 145 | 38 | 4 | int:DAZL | |
| Interaction | TNRC6B interactions | 1.78e-04 | 282 | 38 | 5 | int:TNRC6B | |
| Interaction | CPEB4 interactions | 2.08e-04 | 156 | 38 | 4 | int:CPEB4 | |
| Interaction | CDH10 interactions | 2.26e-04 | 12 | 38 | 2 | int:CDH10 | |
| Interaction | CDH9 interactions | 2.26e-04 | 12 | 38 | 2 | int:CDH9 | |
| Interaction | EIF4ENIF1 interactions | 2.37e-04 | 300 | 38 | 5 | int:EIF4ENIF1 | |
| Interaction | YTHDF1 interactions | 2.45e-04 | 302 | 38 | 5 | int:YTHDF1 | |
| Interaction | CNOT1 interactions | 2.56e-04 | 305 | 38 | 5 | int:CNOT1 | |
| Interaction | CNTROB interactions | 2.63e-04 | 166 | 38 | 4 | int:CNTROB | |
| Interaction | YTHDF2 interactions | 2.84e-04 | 312 | 38 | 5 | int:YTHDF2 | |
| Interaction | EGR2 interactions | 2.95e-04 | 171 | 38 | 4 | int:EGR2 | |
| Interaction | SMAP2 interactions | 4.31e-04 | 189 | 38 | 4 | int:SMAP2 | |
| Interaction | AR interactions | 4.38e-04 | 992 | 38 | 8 | int:AR | |
| Interaction | SMG5 interactions | 5.30e-04 | 84 | 38 | 3 | int:SMG5 | |
| Interaction | GSC interactions | 5.88e-04 | 87 | 38 | 3 | int:GSC | |
| Interaction | CNOT3 interactions | 6.07e-04 | 207 | 38 | 4 | int:CNOT3 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.05e-04 | 13 | 30 | 2 | 1186 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 7.80e-04 | 25 | 30 | 2 | 775 | |
| GeneFamily | RNA binding motif containing | 5.18e-03 | 213 | 30 | 3 | 725 | |
| GeneFamily | Sterile alpha motif domain containing | 9.33e-03 | 88 | 30 | 2 | 760 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN | 1.01e-05 | 200 | 38 | 5 | M9315 | |
| ToppCell | Control-Lymphoid-B|World / Disease state, Lineage and Cell class | 4.49e-07 | 181 | 38 | 5 | 9124f1a610cfc3355ad87921cd3eb5346956475d | |
| ToppCell | Control-Lymphoid-B|Control / Disease state, Lineage and Cell class | 4.87e-07 | 184 | 38 | 5 | de0294f879268bfd68e91adcc2adba211d221b7a | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 7.36e-07 | 200 | 38 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 7.36e-07 | 200 | 38 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 168 | 38 | 4 | 3e3f611e9bbec8224264666be14a4e7db343070e | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-05 | 170 | 38 | 4 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-05 | 171 | 38 | 4 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 1.51e-05 | 176 | 38 | 4 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 1.51e-05 | 176 | 38 | 4 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 177 | 38 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.54e-05 | 177 | 38 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 180 | 38 | 4 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-05 | 180 | 38 | 4 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 180 | 38 | 4 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-05 | 180 | 38 | 4 | b83d067dee641941c596e4a25d81327931b6ad61 | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.64e-05 | 180 | 38 | 4 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.68e-05 | 181 | 38 | 4 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.72e-05 | 182 | 38 | 4 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 182 | 38 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 1.72e-05 | 182 | 38 | 4 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 1.72e-05 | 182 | 38 | 4 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-05 | 182 | 38 | 4 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-05 | 182 | 38 | 4 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.72e-05 | 182 | 38 | 4 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 182 | 38 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-05 | 182 | 38 | 4 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.72e-05 | 182 | 38 | 4 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 1.75e-05 | 183 | 38 | 4 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.75e-05 | 183 | 38 | 4 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-05 | 184 | 38 | 4 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-05 | 184 | 38 | 4 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 184 | 38 | 4 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 1.83e-05 | 185 | 38 | 4 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 185 | 38 | 4 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.83e-05 | 185 | 38 | 4 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-05 | 186 | 38 | 4 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-05 | 186 | 38 | 4 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-05 | 186 | 38 | 4 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | Healthy-HSPC|World / disease group, cell group and cell class | 1.91e-05 | 187 | 38 | 4 | 8cd9e5499e5c2b2321ecbcf780df37fe0f165ac9 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 1.91e-05 | 187 | 38 | 4 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 1.99e-05 | 189 | 38 | 4 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.08e-05 | 191 | 38 | 4 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 194 | 38 | 4 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-05 | 195 | 38 | 4 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 196 | 38 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 38 | 4 | da61afba697ec49ca86e062d35a825280da558ac | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 38 | 4 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 197 | 38 | 4 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 38 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-05 | 198 | 38 | 4 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 2.48e-05 | 200 | 38 | 4 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.48e-05 | 200 | 38 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.64e-04 | 125 | 38 | 3 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 128 | 38 | 3 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.30e-04 | 140 | 38 | 3 | eb1d22f5f5dbf60b6485464baec4be9b3060f65c | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 157 | 38 | 3 | e6846ffd1bb18bf0469bc6d49ab6cf3533d9cde6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-04 | 158 | 38 | 3 | c736834269c89e003c61a62b63e4e50dbf0e1538 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.28e-04 | 158 | 38 | 3 | 4f3ea658e032555c2098d016475381c8d1071699 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 159 | 38 | 3 | 796e63f6052189106359a4e01eae3e466bf1d593 | |
| ToppCell | Control-Mast_cells-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 3.46e-04 | 161 | 38 | 3 | 5807ee48f871a3eb24ebf78fd107cf5f2a4ec846 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-04 | 161 | 38 | 3 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-04 | 161 | 38 | 3 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-04 | 161 | 38 | 3 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-04 | 162 | 38 | 3 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-04 | 162 | 38 | 3 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.59e-04 | 163 | 38 | 3 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 3.59e-04 | 163 | 38 | 3 | 4eac7fd8acdb7f09ce739335f22a879f9b8febfb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-04 | 164 | 38 | 3 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.72e-04 | 165 | 38 | 3 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 166 | 38 | 3 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.78e-04 | 166 | 38 | 3 | 37f5264491d75af690dd94eea2cf7763f42b2a2a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Liver / Manually curated celltypes from each tissue | 3.78e-04 | 166 | 38 | 3 | 9afa33b5ad27dc33576be592f9b22d8161366838 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 3.92e-04 | 168 | 38 | 3 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-04 | 169 | 38 | 3 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.06e-04 | 170 | 38 | 3 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 170 | 38 | 3 | c638dfde9ce30190abbe0caea1c3eb874af09857 | |
| ToppCell | COVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type | 4.13e-04 | 171 | 38 | 3 | a59a054b8e119215f24dc5c80ad5a8094b3500f9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-04 | 172 | 38 | 3 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-04 | 172 | 38 | 3 | 3784fd1e833703519889942e39fda991f03c3c76 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-04 | 172 | 38 | 3 | 995139aa38f8b9ff23166128b15476cd8a3ff1b8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-04 | 172 | 38 | 3 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-04 | 173 | 38 | 3 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 174 | 38 | 3 | 26ca6ebaa0081108d44c01f8ca56a63724f1c99d | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.34e-04 | 174 | 38 | 3 | 66df78280f657978c4a568010ae7d7943869af90 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 174 | 38 | 3 | 7c8704766dd4c80250754b5ee9907b342b9c2623 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 174 | 38 | 3 | 9aa2168d3bcef7cdc5a47442618cb8e9eb24c95b | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-04 | 175 | 38 | 3 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 4.49e-04 | 176 | 38 | 3 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | fc2ba468677b19b55130c1f06737f40300cd9d2e | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 077f3fe5e3482ea3f639d789bd3d584161b36c02 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.49e-04 | 176 | 38 | 3 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 177 | 38 | 3 | a3f8c26d54e44688bbd678ac7ef55d8ad172617d | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-04 | 177 | 38 | 3 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-04 | 177 | 38 | 3 | 7e799333307448c6a94d1f33dbc59c543336f45e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-04 | 178 | 38 | 3 | f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.64e-04 | 178 | 38 | 3 | 8d74c12c4b0ce8bcb0f59151bdc67036997095ef | |
| Drug | guanidinium | 3.02e-06 | 245 | 38 | 6 | CID000003520 | |
| Drug | 2 Md | 8.13e-06 | 3 | 38 | 2 | CID005289549 | |
| Disease | Down syndrome (biomarker_via_orthology) | 1.53e-06 | 2 | 37 | 2 | DOID:14250 (biomarker_via_orthology) | |
| Disease | migraine disorder, type 2 diabetes mellitus | 5.91e-05 | 60 | 37 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | mood instability measurement | 5.56e-04 | 128 | 37 | 3 | EFO_0008475 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 7.41e-04 | 32 | 37 | 2 | EFO_0000341, EFO_0004325 | |
| Disease | dentate gyrus volume measurement | 1.10e-03 | 39 | 37 | 2 | EFO_0010083 | |
| Disease | hippocampal CA4 volume | 1.22e-03 | 41 | 37 | 2 | EFO_0009396 | |
| Disease | neuroimaging measurement | 1.98e-03 | 1069 | 37 | 6 | EFO_0004346 | |
| Disease | liver cirrhosis (is_marker_for) | 4.77e-03 | 82 | 37 | 2 | DOID:5082 (is_marker_for) | |
| Disease | irritability measurement | 4.77e-03 | 82 | 37 | 2 | EFO_0009594 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IMENSGIQMVSKNGN | 446 | Q96QE3 | |
| EQMMKAGEQGQQQRI | 311 | Q7RTX7 | |
| QAAIQSMNGFQIGMK | 456 | Q92879 | |
| QTAIQAMNGFQIGMK | 451 | Q96J87 | |
| VDMKAQGMAQSQGEA | 506 | Q5H9R4 | |
| DQSNNEIMIGVMSGG | 226 | P29074 | |
| LAGMGGIQNEKETMQ | 71 | P05783 | |
| GSMVNGMQNQDPVGQ | 1306 | P10071 | |
| MMAQKSQGSDNLQEG | 1 | Q6ZRS4 | |
| GADNVGSKQMQQIRM | 31 | P05388 | |
| GTVQGGDNFQMEMSQ | 366 | P17301 | |
| KESQEAQNIAGGSMM | 2246 | Q9UPN3 | |
| MQGNMVQFTGQMSGQ | 751 | Q14686 | |
| GGMTNNKVLMQLQAD | 426 | Q14410 | |
| MCFGFVIGNMKEQGQ | 251 | P43003 | |
| MKGDVNLNVNMGSNS | 716 | O00512 | |
| QAMNNAMKENGQAGA | 361 | P51841 | |
| QNFMLMKQRGVGGEV | 1431 | Q86UU0 | |
| RNIGNAGMVAGMENN | 381 | Q12912 | |
| QYQVVIQAKDMGGQM | 231 | P55285 | |
| QYQVVIQAKDMGGQM | 231 | Q9ULB4 | |
| DQEMQAIGGQKVNMP | 106 | Q7L3T8 | |
| GADNVGSKQMQQIRM | 31 | Q8NHW5 | |
| QGEMREMQQLSGGQK | 1106 | Q9UQE7 | |
| QFQQGAAGNMKGMMG | 486 | P61011 | |
| QGQEAAVMMDQKAGL | 1096 | Q9Y6Q9 | |
| VETIPMKNMENGNNG | 831 | O43490 | |
| MENKENGSVGVKNSM | 26 | Q5VXD3 | |
| VKQGAENMIQMYSNG | 151 | Q16513 | |
| QTAIQAMNGFQIGMK | 456 | Q9BZC1 | |
| MGQKQAQQVMEGTGA | 2361 | A5YKK6 | |
| GTGMIGENEQEKKMQ | 201 | P52747 | |
| GQSMDDGMINVAKQL | 786 | Q99973 | |
| EQIQCMQEMGNGKAN | 76 | Q8WU79 | |
| GAQQGGAQQKAMAAM | 146 | Q8IYN6 | |
| MNGEQQLDADAGSGM | 1 | Q9UHJ3 | |
| MAQQGQQGQMASGDS | 1 | Q13342 | |
| NVQSNKMDLSGGMLQ | 1221 | Q8NDV7 |